in an attempt to further improve on the encouraging results achieved by high-dose cytosine arabinoside ( hd arac ) and mitoxantrone ( ham ) in refractory acute leukemias , a timely modified sequential schedule of both drugs was developed ( s-ham ) and applied to 13 patients with far advanced acute leukemias , 8 of whom had been treated with the original ham protocol before .
C0010711
cytosine arabinoside
C0068899
s-ham